跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Creon 25000 capsule, coated pellets 300mg - HSA Drug Approval Details
Approvals
/
HSA
/
Creon 25000 capsule, coated pellets 300mg
Approved
THERAPEUTIC
Creon 25000 capsule, coated pellets 300mg
Abbott Laboratories GmbH (GERMANY)
🇸🇬 Health Sciences Authority
Approval Date
Apr 10, 2026
Approval ID
d05c9aebba21d72b
Company
Abbott Laboratories GmbH (GERMANY)
Type
Therapeutic
Approval Details
Approval Id
d05c9aebba21d72b
Drug Name
Creon 25000 capsule, coated pellets 300mg
Product Name
Creon 25000 capsule, coated pellets 300mg
Approval Number
SIN17515P
Approval Date
2026-04-10
Registrant
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE, COATED PELLETS
Route Of Administration
ORAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 10, 2026
Approval ID
d05c9aebba21d72b
Type
Therapeutic
Back to HSA Approvals